Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates

被引:103
作者
Frankfurt, O
Rosen, ST
机构
[1] Northwestern Memorial Hospital, Robert H. Lurie Compreh. Cancer Ctr.
[2] Chicago, IL 60611
关键词
apoptosis; glucocorticoids; glucocorticoid receptor; caspases;
D O I
10.1097/01.cco.0000142072.22226.09
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of review Glucocorticoids remain a central component of the therapeutic armamentarium for a broad spectrum of hematologic malignancies. There is an extensive body of evidence suggesting that the efficacy of glucocorticoids stems from their ability to mediate apoptosis in leukemia, lymphoma, and myeloma cells. Recent findings Traditionally, glucocorticoid-induced apoptosis is divided into three stages: an initiation stage, which involves glucocorticoid receptor activation and glucocorticoid receptor-mediated gene regulation; a decision stage, which engages the prosurvival and proapoptotic factors at the mitochondrial level; and an execution stage, which implicates caspases and endonuclease activation. Recent discoveries have clarified many aspects of the apoptotic pathway, including activation of the caspases cascade and multicatalytic proteasome, suppression of prosurvival transcription factors such as AP-1, c-myc, nuclear factor-kappaB, as well as cross-talk between the T-cell receptor and cytokine signaling pathways. Summary This review focuses primarily on insights gained during recent years into the mechanism of the signaling pathways responsible for mediating glucocorticoid-induced apoptosis in hematologic malignancies. This information provides a scientific basis to explore synergistic approaches that may enhance glucocorticoid-induced apoptosis and may bypass mechanism of resistance.
引用
收藏
页码:553 / 563
页数:11
相关论文
共 140 条
[1]   Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation:: preferential targetting of NF-κB and lack of I-κB involvement [J].
Adcock, IM ;
Nasuhara, Y ;
Stevens, DA ;
Barnes, PJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (04) :1003-1011
[2]  
ALNEMRI ES, 1992, CANCER RES, V52, P491
[3]   Induction of thymocyte apoptosis by Ca2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation [J].
Asada, A ;
Zhao, Y ;
Kondo, S ;
Iwata, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :28392-28398
[4]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[5]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[6]  
Auphan N, 1997, Arch Toxicol Suppl, V19, P87
[7]   Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells [J].
Ausserlechner, MJ ;
Obexer, P ;
Böck, G ;
Geley, S ;
Kofler, R .
CELL DEATH AND DIFFERENTIATION, 2004, 11 (02) :165-174
[8]   GLUCOCORTICOID RECEPTOR-BETA, A POTENTIAL ENDOGENOUS INHIBITOR OF GLUCOCORTICOID ACTION IN HUMANS [J].
BAMBERGER, CM ;
BAMBERGER, AM ;
DECASTRO, M ;
CHROUSOS, GP .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2435-2441
[9]   Anti-inflammatory mechanisms of glucocorticoids [J].
Barnes, PJ .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (04) :940-945
[10]   ANTIINFLAMMATORY ACTIONS OF STEROIDS - MOLECULAR MECHANISMS [J].
BARNES, PJ ;
ADCOCK, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (12) :436-441